
|Videos|September 20, 2016
Hidden Costs for Patients Starting a Specialty Drug Regimen
Author(s)Lauren Santye, Assistant Editor
Marc O'Connor, COO and chief strategy officer at Curant Health, discusses the out-of-pocket costs that can emerge for patients starting a specialty medication regimen.
Advertisement
Marc O'Connor, COO and chief strategy officer at Curant Health, discusses the out-of-pocket costs that can emerge for patients starting a specialty medication regimen.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1s and Muscle Loss: The Conversation Pharmacists Are Not Having, But Should Be
2
AHA/ACC CKM Guideline Formally Endorses GLP-1 Therapies for Kidney, Heart Protection
3
Montelukast Prophylaxis Reduces Rituximab Infusion Reactions in Oncology Patients
4
Afami-cel Receives Full FDA Approval, Expanded Indication to Treat Pediatric Patients With Synovial Sarcoma
5





















































































































